![mitochondrial](https://www.adcreviews.com/wp-content/uploads/2022/09/mitochondrial-300x97.jpg)
Pretzel’s innovative therapy to modulate mitochondrial function receives Series A funding
On September 12, Pretzel Therapeutics, a biotechnology company, announced the completion of a $72.5 million Series A financing to pioneer innovative therapies that modulate mitochondrial